97992-01-3 Usage
Uses
Used in Pharmaceutical Development:
(2S)-2-amino-N-[(1R)-1-[[(1R)-1-(carbamoylmethylcarbamoyl)-2-phenyl-ethyl]carbamoyl]ethyl]-3-(4-hydroxyphenyl)propanamide is utilized as a potential drug candidate for its structural similarity to bioactive peptides and its capacity to interact with specific cellular targets, which may contribute to the advancement of novel therapeutic agents.
Used in Neurobiology Research:
In the field of neurobiology, (2S)-2-amino-N-[(1R)-1-[[(1R)-1-(carbamoylmethylcarbamoyl)-2-phenyl-et hyl]carbamoyl]ethyl]-3-(4-hydroxyphenyl)propanamide serves as a valuable tool for studying the interactions between peptides and cellular targets, potentially leading to a better understanding of neurological processes and the development of treatments for related conditions.
Used in Medical Research:
(2S)-2-amino-N-[(1R)-1-[[(1R)-1-(carbamoylmethylcarbamoyl)-2-phenyl-ethyl]carbamoyl]ethyl]-3-(4-hydroxyphenyl)propanamide is employed as a research molecule to explore its binding properties and potential effects on cellular processes, which could contribute to the discovery of new medical interventions and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 97992-01-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,9,9 and 2 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 97992-01:
(7*9)+(6*7)+(5*9)+(4*9)+(3*2)+(2*0)+(1*1)=193
193 % 10 = 3
So 97992-01-3 is a valid CAS Registry Number.
InChI:InChI=1/C23H29N5O5/c1-14(27-22(32)18(24)11-16-7-9-17(29)10-8-16)21(31)28-19(23(33)26-13-20(25)30)12-15-5-3-2-4-6-15/h2-10,14,18-19,29H,11-13,24H2,1H3,(H2,25,30)(H,26,33)(H,27,32)(H,28,31)/t14-,18+,19-/m1/s1
97992-01-3Relevant academic research and scientific papers
FIRST DIRECT FLUORINATION OF TYROSINE-CONTAINING BIOLOGICALLY ACTIVE PEPTIDES
Hebel, D.,Kirk, K.L.,Cohen, L.A.,Labroo, V.M.
, p. 619 - 622 (2007/10/02)
Using acetyl hypofluorite a regiospecific electrophilic fluorination of the tyrosine ring of the N-terminal tetrapeptide amide (Tyr-D-Ala-Phe-Gly-NH2) sequence of the opiate peptide dermorphin has been achieved in good yields.
Synthesis and pharmacological activity of dermorphin tetrapeptide-analogs
Salvadori,Sarto,Tomatis
, p. 489 - 493 (2007/10/02)
The authors report on the synthesis and pharmacological activity of twenty-four tetrapeptide-analogs of the opioid heptapeptide dermorphin; their terminal amino group were replaced by guanidino functions and/or the C-termini were changed into amide moieti
